Indian Army Medicines Tender 2026: Ophthalmic Lignocaine, Oxytocin, Dexamethasone, Amikacin – BBQR Compliant Supply

Tender Overview

The Indian Army, under the Department of Military Affairs, issues a medical consumables tender seeking multiple injectable and ophthalmic pharmaceutical products, with a focus on compliance to BBQR specifications. Key items include Lignocaine HCl 2% (without Adrenaline) 30 ml, Oxytocin 5 units per 1 ml ampoule, Dexamethasone Sodium Phosphate 4 mg/ml, Amikacin Sulphate 250 mg/2 ml, Mupirocin 2% ointment 5 g, Magnesium sulfate 50% IV, Diclofenac 75 mg/ml, Labetalol HCl 5 mg/ml, and Hydrogen peroxide IP 20 volumes. The estimated total quantity is governed by the option to adjust up to 50% of bid quantity during contract, with delivery aligned to a last-date-of-order trigger. EMD is ₹6,433. The tender requires strict BBQR compliance and submission of OEM authorizations, turnover data, and past performance. The scope emphasizes shelf-life management for indigenous vs foreign products and stock replacement obligations. The procurement backdrop centers on CFA/BBQR-delivered approvals and a technical evaluation committee’s binding decisions. The tender highlights indigenous drug shelf-life and stock replacement rules, ensuring supply continuity.

Technical Specifications & Requirements

• Items: Ophthalmic and injectable medicines including Lignocaine HCl 2% (without Adrenaline) 30 ml, Oxytocin 5 units per 1 ml amp, Dexamethasone Sodium Phosphate 4.4 mg/ml equivalent to 4 mg/ml 2 ml, Amikacin Sulphate 250 mg/2 ml, Diclofenac 75 mg/1 ml amp, Mupirocin 2% ointment 5 g, Magnesium sulfate 50% IV, Labetalol HCl 5 mg/ml 4 ml, Hydrogen peroxide IP 20 volumes 500 ml bottle.
• Standards/Compliance: BBQR specification compliance mandatory; indigenous drugs shelf-life 5/6 of shelf life at supply; foreign products 2/3 shelf life; shelf-life acceptance at CFA discretion.
• Documentation: OEM Authorization Certificate, Bidder Turnover details, Past Performance, Technical compliance with BoQ specifications, and “Compliance of BBQR specification” documents.
• Delivery/Packaging: Deliver per last-date-of-delivery with option to extend; stock replacement obligations for unconsumed or defective stock within shelf life; avoidance of substituting medicines with health supplements.
• Tender Scope Notes: 11 total items in BOQ with non-listed quantities; full compliance with BBQR for all quoted schedules; brochure submission prior to bid opening; address for brochure delivery: Command Hospital (EC), Alipore, Kolkata.

Terms, Conditions & Eligibility

• EMD: ₹6,433 required for bid submission.
• Delivery Extension: Option to increase quantity up to 50% during contract, with time proportionality formula and minimum 30 days.
• Shelf Life Rules: Indigenous drugs must have 5/6 of shelf life remaining; foreign products 2/3; CFA discretion for acceptance below quoted shelf life.
• Documentation: Upload MII Documents, Experience Criteria, Past Performance, OEM Authorization Cert, and OEM Annual Turnover; include BBQR compliance documents.
• Replacement Obligation: Replace unconsumed stock before 3 months of expiry; replace defective stock during shelf life.
• Prohibitions: Do not quote health supplements in place of medicines unless explicitly requested; non-medical substitutes automatically rejected.
• Evaluation: Technical Evaluation Committee decisions are final and binding; brochure submission to specific address is mandatory prior to opening.
• Fund Code: 363/01.